State Ledger
Company profile

CITIUS ONCOLOGY, INC. CIK 1851484

Ticker
CTOR (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Cranford, NJ 07016
Fiscal year end
2025 (FY)
Market Data
Close
$0.83
Change
+$0.02
Change %
2.88%
Volume
241

CTOR · trading date Oct 12, 2026 · previous close $0.81 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$24.76M
Total assets
$100.94M
Total liabilities
$56.08M
Stockholders' equity
$44.87M
Cash & equivalents
$3.92M
Operating income
-$23.52M
Operating cash flow
-$5.49M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2025-12-23. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
55.6%
Equity / assets
44.4%
CapEx / revenue
—
Operating cash flow / net income
0.22×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$24.76M $100.94M $56.08M $44.87M
2024 — -$21.15M $84.37M $38.23M $46.14M
2023 — $2.42M $72.62M — -$1.99M
2022 — $380.8K $68.19M — $345.5K
2021 — — $126.4K — -$10.1K
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form ARS
2026-08-26
Financials filed via
Form 10-K
filed 2025-12-23

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Cranford, NJ 07016
11 COMMERCE DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies